Keyphrases
Treatment Response
100%
Crohn's Disease
100%
Fibronectin
100%
Collagen III
100%
Tissue Markers
100%
Anti-tumor Necrosis Factor Agents
100%
Response Predictors
66%
Terminal Ileum
66%
Anti-tumor Necrosis Factor (anti-TNF)
66%
Group-based
33%
Treatment Initiation
33%
Interleukin
33%
Response to Therapy
33%
Laboratory Parameters
33%
Hypoxia-inducible factor-1α (HIF-1α)
33%
Immunofluorescence
33%
Pediatric Patients
33%
Immunofluorescence Analysis
33%
Clinical Parameters
33%
Interleukin-23 (IL-23)
33%
Partial Response
33%
Colonic Diseases
33%
Ileal Diseases
33%
Interleukin-23R
33%
Anti-TNF Treatment
33%
TNF Agents
33%
Parameter Groups
33%
Ileal Crohn's Disease
33%
Primary Nonresponse
33%
Medicine and Dentistry
Treatment Response
100%
Tumor Necrosis Factor
100%
Crohn's Disease
100%
Necrosis
100%
Fibronectin
50%
Cytokine
33%
Immunofluorescence
33%
Terminal Ileum
33%
Biopsy
33%
Hypoxia Inducible Factor 1
16%
Pediatrics Patient
16%
Colon Disease
16%
Mating Hormone Alpha Factor
16%
Colon Crohn Disease
16%
Interleukin 23
16%
Ileum Disease
16%
Pharmacology, Toxicology and Pharmaceutical Science
Tumor Necrosis Factor
100%
Necrosis
100%
Crohn's Disease
100%
Fibronectin
50%
Cytokine
33%
Ileum
33%
Hypoxia Inducible Factor 1
16%
Colon Disease
16%
Mating Hormone Alpha Factor
16%
Interleukin 23
16%
Colon Crohn Disease
16%
Ileum Disease
16%
Immunology and Microbiology
Tumor Necrosis Factor
100%
Crohn's Disease
100%
Fibronectin
60%
Interleukin
40%
Cytokine
40%
Immunofluorescence
40%
Terminal Ileum
40%
Monospecific Antibody
20%
Tumor Necrosis Factor Alpha
20%
Hypoxia Inducible Factor 1
20%
Interleukin 23
20%